PRESS-RELEASE filed Jul 16, 2026 at 16:05 ET
Intuitive Surgical reported Q2 2026 non-GAAP EPS of $2.80, beating consensus of $2.59 by 8.2%, on revenue of $2.89B (in line with $2.89B consensus, +19% YoY). Worldwide procedure growth of ~16% and strong da Vinci 5 placements (246 systems) drove results, but the stock's historical pattern shows poor follow-through on bullish calls, and the guidance midpoint implies decelerating procedure growth to ~14.5% for full-year 2026, tempering the beat's impact.